Detail Information of Transcriptional Regulations
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0118 Transporter Info | ||||
| Gene Name | SLC17A5 | ||||
| Transporter Name | Vesicular H(+)/Aspartate-glutamate cotransporter | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Transcriptional Regulation of This DT (TSR) | ||||||
|---|---|---|---|---|---|---|
|
Class 1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
|
CEBPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [1] | ||||
|
TF Protein Name |
CCAAT/enhancer-binding protein alpha | Transcription Factor Info | ||||
|
Tissue |
Embryo | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
CCAAT/enhancer-binding protein alpha (CEBPA) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [2] | ||||
|
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
|
Tissue |
Blood | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
CEBPD |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [3] | ||||
|
TF Protein Name |
CCAAT/enhancer-binding protein delta | Transcription Factor Info | ||||
|
Tissue |
Aorta | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
CCAAT/enhancer-binding protein delta (CEBPD) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [4] | ||||
|
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
|
Tissue |
Embryo; Liver; Uterus | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
FOS |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [1] | ||||
|
TF Protein Name |
Protein c-Fos | Transcription Factor Info | ||||
|
Tissue |
Breast | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Protein c-Fos (FOS) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
XBP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [2] | ||||
|
TF Protein Name |
X-box-binding protein 1 | Transcription Factor Info | ||||
|
Tissue |
Breast | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
X-box-binding protein 1 (XBP1) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
|
ASCL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [4] | ||||
|
TF Protein Name |
Achaete-scute homolog 1 | Transcription Factor Info | ||||
|
Tissue |
Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Achaete-scute homolog 1 (ASCL1) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
LYL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [3] | ||||
|
TF Protein Name |
Protein lyl-1 | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow; Colon | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Protein lyl-1 (LYL1) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
Class 2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
|
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [4] | ||||
|
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
GATA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [1] | ||||
|
TF Protein Name |
Endothelial transcription factor GATA-2 | Transcription Factor Info | ||||
|
Tissue |
Blood | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Endothelial transcription factor GATA-2 (GATA2) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
Class 2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
|
CTCF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [3] | ||||
|
TF Protein Name |
Transcriptional repressor CTCF | Transcription Factor Info | ||||
|
Tissue |
Brain | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcriptional repressor CTCF (CTCF) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [2] | ||||
|
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow; Cervix; Liver; Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
Class 3.1: Homeo domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
PBX3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [4] | ||||
|
TF Protein Name |
Pre-B-cell leukemia transcription factor 3 | Transcription Factor Info | ||||
|
Tissue |
Blood | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Pre-B-cell leukemia transcription factor 3 (PBX3) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
|
E2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [4] | ||||
|
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
|
Tissue |
Mesenchymal | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription factor E2F1 (E2F1) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [3] | ||||
|
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
|
Tissue |
Breast; Embryo; Liver; Pancreatic ductal; Prostate | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [4] | ||||
|
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
|
Tissue |
Embryo; Liver; Lung; Skin | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
Class 3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
|
ERG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [1] | ||||
|
TF Protein Name |
Transcriptional regulator ERG | Transcription Factor Info | ||||
|
Tissue |
Blood | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcriptional regulator ERG (ERG) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
ETS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [2] | ||||
|
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone; Bone marrow; Kidney; Lung; Vein | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Protein C-ets-1 (ETS1) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
ETS2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [1] | ||||
|
TF Protein Name |
Protein C-ets-2 | Transcription Factor Info | ||||
|
Tissue |
Colon | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Protein C-ets-2 (ETS2) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [2] | ||||
|
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
|
Tissue |
Blood; Mesenchymal | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [3] | ||||
|
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
|
Tissue |
Brain; Liver | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [1] | ||||
|
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
|
Tissue |
Adrenal gland; Blood; Bone marrow; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
|
Class 10.1: Other factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
GTF2B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A5 gene | [2] | ||||
|
TF Protein Name |
Transcription initiation factor IIB | Transcription Factor Info | ||||
|
Tissue |
Cervix; Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription initiation factor IIB (GTF2B) can directly bind to the SLC17A5 gene, which in turn affects the expression or function of the drug transporter Vesicular H(+)/Aspartate-glutamate cotransporter. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.